• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症化疗的心血管毒性。

Cardiovascular toxicities of cancer chemotherapy.

机构信息

Department of Medicine, Division of Cardiology, Jefferson Heart Institute, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

出版信息

Semin Oncol. 2013 Apr;40(2):156-67. doi: 10.1053/j.seminoncol.2013.01.004.

DOI:10.1053/j.seminoncol.2013.01.004
PMID:23540741
Abstract

Cancer chemotherapy has improved over the years with the advent of newer agents, including more targeted chemotherapeutic drugs, resulting in better patient survival. However, with continued use and patient exposure to these drugs, important cardiovascular adverse effects are becoming realized, such as left ventricular dysfunction and heart failure, myocardial ischemia, hypertension, arrhythmias, and pulmonary arterial hypertension. In this article, we review the most common cardiovascular toxicities and their related pathophysiology that occur with the use of these agents.

摘要

随着新型药物(包括更具针对性的化疗药物)的出现,癌症化疗在这些年得到了改善,这使得患者的生存率得到了提高。然而,随着这些药物的持续使用和患者接触,重要的心血管不良事件也逐渐显现,如左心室功能障碍和心力衰竭、心肌缺血、高血压、心律失常和肺动脉高压。本文综述了这些药物使用过程中常见的心血管毒性及其相关病理生理学。

相似文献

1
Cardiovascular toxicities of cancer chemotherapy.癌症化疗的心血管毒性。
Semin Oncol. 2013 Apr;40(2):156-67. doi: 10.1053/j.seminoncol.2013.01.004.
2
Cardiac testing to manage cardiovascular risk in cancer patients.对癌症患者进行心脏检测以管理心血管风险。
Semin Oncol. 2013 Apr;40(2):147-55. doi: 10.1053/j.seminoncol.2013.01.003.
3
Detection and prevention of cardiac complications of cancer chemotherapy.癌症化疗中心血管并发症的检测与预防。
Arch Cardiovasc Dis. 2012 Nov;105(11):593-604. doi: 10.1016/j.acvd.2012.04.008. Epub 2012 Oct 4.
4
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.蒽环类化疗后乳腺癌的心脏毒性:对左心室射血分数、肌钙蛋白 I 和脑利钠肽的影响。
Int J Cardiol. 2011 Apr 14;148(2):194-8. doi: 10.1016/j.ijcard.2009.09.564. Epub 2009 Nov 27.
5
Anthracycline-related cardiotoxicity in childhood cancer survivors.蒽环类药物相关性心脏毒性在儿童癌症幸存者中的研究进展。
Curr Opin Cardiol. 2014 Jan;29(1):103-12. doi: 10.1097/HCO.0000000000000034.
6
[Cardiovascular complications of chemotherapy].[化疗的心血管并发症]
G Ital Cardiol (Rome). 2012 Oct;13(10 Suppl 2):165S-170S. doi: 10.1714/1167.12943.
7
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.预防蒽环类药物引起的心肌损伤:最具前景策略的综述
Br J Haematol. 2005 Dec;131(5):561-78. doi: 10.1111/j.1365-2141.2005.05759.x.
8
The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients.晚期肾细胞癌患者接受靶向治疗的心血管毒性的频率和严重程度。
JACC Heart Fail. 2013 Feb;1(1):72-8. doi: 10.1016/j.jchf.2012.09.001. Epub 2013 Feb 4.
9
Cardiac toxicity of targeted therapies used in the treatment for solid tumours: a review.靶向治疗药物治疗实体瘤的心脏毒性:综述。
Cardiovasc Toxicol. 2012 Sep;12(3):191-207. doi: 10.1007/s12012-012-9164-0.
10
Brain natriuretic peptide as a cardiotoxicity biomarker in children with hematological malignancies.脑钠肽作为血液系统恶性肿瘤患儿心脏毒性的生物标志物。
Minerva Pediatr. 2012 Jun;64(3):307-12.

引用本文的文献

1
Cardiac MRI for differentiating chemotherapy-induced cardiotoxicity in sarcoma and breast cancer.心脏磁共振成像用于鉴别肉瘤和乳腺癌中化疗引起的心脏毒性。
Radiol Oncol. 2025 Feb 27;59(1):79-90. doi: 10.2478/raon-2025-0012. eCollection 2025 Mar 1.
2
Risk of adverse birth outcomes after adolescent and young adult cancer.青少年和青年期癌症后不良生育结局的风险。
JNCI Cancer Spectr. 2024 Jan 4;8(1). doi: 10.1093/jncics/pkad106.
3
The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort.青少年和年轻成人(AYA)地平线研究:一项 AYA 癌症生存者队列研究。
Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):857-866. doi: 10.1158/1055-9965.EPI-20-1315. Epub 2021 Feb 22.
4
Redox-Responsive Disulfide Bond-Bridged mPEG-PBLA Prodrug Micelles for Enhanced Paclitaxel Biosafety and Antitumor Efficacy.用于增强紫杉醇生物安全性和抗肿瘤疗效的氧化还原响应性二硫键桥联mPEG-PBLA前药胶束
Front Oncol. 2019 Aug 27;9:823. doi: 10.3389/fonc.2019.00823. eCollection 2019.
5
Surviving Cancer without a Broken Heart.战胜癌症,心不破碎。
Rambam Maimonides Med J. 2019 Apr 18;10(2):e0012. doi: 10.5041/RMMJ.10366.
6
Risk of Adverse Obstetric Outcomes and the Abnormal Growth of Offspring in Women with a History of Thyroid Cancer.甲状腺癌病史女性的不良产科结局和子代生长异常风险。
Thyroid. 2019 Jun;29(6):879-885. doi: 10.1089/thy.2018.0283. Epub 2019 May 9.
7
The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology.第十届双年度哈特心血管研究所研讨会:细胞保护——评估心肌梗死、缺血性中风和心脏肿瘤学领域的新方向。
Basic Res Cardiol. 2018 Oct 11;113(6):43. doi: 10.1007/s00395-018-0704-z.
8
Live birth outcomes after adolescent and young adult breast cancer.青少年和青年期乳腺癌患者的活产结局。
Int J Cancer. 2018 May 15;142(10):1994-2002. doi: 10.1002/ijc.31227. Epub 2018 Jan 4.
9
Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.跳出油锅又入火坑:癌症治疗后的损伤相关分子模式与心血管毒性
Ther Adv Cardiovasc Dis. 2017 Nov;11(11):297-317. doi: 10.1177/1753944717729141. Epub 2017 Sep 15.
10
Birth Outcomes Among Adolescent and Young Adult Cancer Survivors.青少年和青年癌症幸存者的生育结局。
JAMA Oncol. 2017 Aug 1;3(8):1078-1084. doi: 10.1001/jamaoncol.2017.0029.